Jalavetasa (Indian Willow) in Ayurveda: Properties & Everyday Use

What it is

Jalavetasa (Salix tetrasperma Roxb.), family Salicaceae, is the Indian willow, a riverside tree of South and Southeast Asia. The bark is the medicinal part. Its signature constituents are salicin and a family of salicin derivatives, alongside flavonoids (quercetin, kaempferol), tannins, and phenolic acids.

The genus Salix has a long folk tradition of easing pain and inflammation (J Agric Food Chem, 2024), and it is the historical source of salicylic acid, the template for aspirin. This is one of the rare cases where a traditional plant and a modern drug share a direct chemical lineage.

Classical properties

• Taste (rasa): bitter (Tikta)
• Qualities (guna): light (Laghu)
• Potency (virya): cooling (Sheeta)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Pitta and Kapha; may increase Vata

Traditional use

Ayurvedic texts place Jalavetasa in the Guduchyadi varga (Bhavaprakasha) and related groupings, using the bark for fever, pain, and inflammation, with astringent applications consistent with its tannin content. Folk use adds headache and itching.

Rasa-panchaka per classical sources: bitter and astringent tastes (Tikta, Kashaya), light and dry qualities (Laghu, Ruksha), cooling potency (Sheeta), pungent post-digestive effect (Katu vipaka). It pacifies Kapha and Pitta. Traditional framing. The research record follows separately.

What research has looked at

Neuropathic pain (animal study)

A flower extract of S. tetrasperma attenuated thermal and mechanical pain behaviors in rats with chronic constriction injury (a neuropathic pain model). It showed peripheral and central analgesic, anti-inflammatory, and antipyretic effects. Mechanistically it suppressed NF-κB, iNOS, NOX, and COX-2 activation and TNF-α and PGE2 signaling (animal study, Antioxidants, 2019) (MDPI).

Notably, the authors reported the extract was relatively safe for stomach and liver at both doses tested. But they flagged a renal risk at the low dose. Animal finding; read the renal note before assuming "natural aspirin" means harmless.

Anti-inflammatory salicin derivatives (in vitro)

Ten previously undescribed salicin derivatives plus five known congeners were isolated from S. tetrasperma bark. Three significantly inhibited nitric oxide production in LPS-stimulated RAW 264.7 macrophages. The most active suppressed IL-1β and IL-6 and reduced iNOS and COX-2 expression, apparently via MAPK and NF-κB pathways (in vitro study, J Agricultural and Food Chemistry, 2024) (ACS).

This is compound-level evidence that the bark's salicin family is genuinely anti-inflammatory. But at the bench, not in patients.

What the evidence does not support (yet)

No human clinical trials of Salix tetrasperma itself were identified. Human trials of willow bark generally (mostly S. alba) exist for back pain and osteoarthritis, but those concern a different species and standardized extracts, and cannot be transferred to Jalavetasa. The traditional fever and pain uses rest on chemistry and animal data, not on trials of this plant.

Safety notes

Because S. tetrasperma bark contains salicin-type compounds, one caution transfers cleanly: people with a history of allergy to salicylates should avoid it. An EFSA systematic review of white willow bark found very limited toxicity data overall and flagged anaphylactic reactions in salicylate-allergic people. It raised a separate concern: willow's tendency to concentrate heavy metals, mainly cadmium, from soil (EFSA Journal, 2018). Beyond that, no systematic safety data for this species exist.

Species-specific data are thin: the rat neuropathic-pain study flagged a possible renal risk at the lower dose tested: an honest signal that this is not a side-effect-free plant (MDPI). No data on pregnancy, breastfeeding, or drug interactions for S. tetrasperma.

FAQs

What is Jalavetasa?

Jalavetasa is Indian willow (Salix tetrasperma). Ayurveda uses its bark for fever, pain, and inflammation. It belongs to the willow genus whose salicin chemistry led to aspirin.

Is Jalavetasa the same as aspirin?

No. It contains salicin-type compounds related to salicylic acid, with overlapping anti-inflammatory and analgesic pharmacology. But it is an unstandardized plant preparation with no human trials, not a measured drug.

Does research support Jalavetasa for pain?

In rats, a flower extract reduced neuropathic pain behaviors; in cell culture, bark salicin derivatives suppressed inflammatory mediators. No human trials of this species exist.

Is Jalavetasa safe?

Human safety data do not exist for this species. A rat study flagged a possible renal risk at the low dose. Anyone who must avoid aspirin or salicylates (allergy, bleeding risk, blood-thinner use) should treat this herb with the same caution.

What is the recommended dose?

Swastik does not suggest amounts. The right amount depends on the person, the preparation and the product, so check with a qualified Ayurvedic practitioner or your doctor before taking any herb.

Annotated Sources

The neuropathic-pain study (rat CCI model, NF-κB/TNF-α/NOX/iNOS modulation, renal-risk note) is Antioxidants 8(10), 2019 (MDPI). The salicin-derivative study (15 compounds, NO/IL-1β/IL-6/iNOS/COX-2 inhibition in macrophages) is Journal of Agricultural and Food Chemistry 72(16), 2024 (ACS). General willow-bark safety: EFSA's systematic review notes very limited toxicity data, anaphylactic risk in salicylate-allergic people, and a heavy-metal (cadmium) concern (EFSA Journal, 2018).

Disclaimer

This article is for educational purposes only and is not medical advice. Jalavetasa contains salicylate-type compounds and shares cautions with aspirin-class drugs; it has no human-trial evidence for this species. Talk to a qualified healthcare practitioner before use — especially if pregnant, breastfeeding, allergic to aspirin, taking blood thinners or NSAIDs, managing a medical condition, or taking prescription medicines.